Skip to main content
. 2018 Mar 14;293(18):6925–6941. doi: 10.1074/jbc.RA118.002566

Figure 11.

Figure 11.

Summary of metabolic pathways and targets affected by adrenergic deficiency during embryonic heart development. Shown is a schematic representation of metabolites and enzymes of PPP, glycolysis, and TCA cycle. Metabolites and enzymes are significantly lower in adrenergic hormone-deficient embryos compared with competent controls as indicated in red or by the red symbol, respectively.